$1.04 Billion is the total value of Alphabet Inc.'s 17 reported holdings in Q3 2018. The portfolio turnover from Q2 2018 to Q3 2018 was 60.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
ZS | Sell | Zscaler Inc | $59,058,000 | -40.8% | 1,448,219 | -48.1% | 5.66% | -32.4% |
CLDR | Sell | Cloudera Inc | $7,549,000 | -35.3% | 427,710 | -50.0% | 0.72% | -26.2% |
SQ | Exit | Square Inccl a | $0 | – | -29,400 | -100.0% | -0.15% | – |
DNLI | Exit | Denali Therapeutics Inc | $0 | – | -536,411 | -100.0% | -0.69% | – |
ASNS | Exit | Arsanis Inc | $0 | – | -451,362 | -100.0% | -0.83% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-15
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
SPERO THERAPEUTICS INC | 24 | Q3 2023 | 3.5% |
AUTOLUS THERAPEUTICS PLC | 22 | Q3 2023 | 2.8% |
Magenta Therapeutics Inc. | 21 | Q2 2023 | 3.8% |
DEXCOM INC | 20 | Q3 2023 | 17.4% |
Evelo Biosciences Inc. | 20 | Q1 2023 | 1.6% |
ALECTOR INC | 19 | Q3 2023 | 1.1% |
Lyft Inc | 18 | Q2 2023 | 51.9% |
QUINCE THERAPEUTICS INC | 18 | Q3 2023 | 0.6% |
Arcus Biosciences Inc | 17 | Q1 2022 | 12.7% |
FULCRUM THERAPEUTICS INC | 17 | Q3 2023 | 0.7% |
View Alphabet Inc.'s complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
ARRIS International plc | February 14, 2019 | 7,603,500 | 4.4% |
View Alphabet Inc.'s complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
PX14A6G | 2024-05-16 |
144 | 2024-05-15 |
144 | 2024-05-15 |
4 | 2024-05-15 |
4 | 2024-05-14 |
144 | 2024-05-13 |
4 | 2024-05-13 |
PX14A6G | 2024-05-08 |
PX14A6G | 2024-05-07 |
PX14A6G | 2024-05-06 |
View Alphabet Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.